Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The Journal of Clinical Investigation
|
January 28, 2006
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
Marco Prinz, Folker Garbe, Hauke Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2016
Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma
William T Curry, Ramana Gorrepati, Matthias Piesche, et al.
Frontiers in Pharmacology
|
March 22, 2021
Effects of Interleukin-1β in Glycinergic Transmission at the Central Amygdala
Jocelyn Solorza, Carolina A Oliva, Karen Castillo, et al.
Cancer Immunology Research
|
May 6, 2017
Combined Anti-VEGF and Anti-CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes
Xinqi Wu, Jingjing Li, Erin M Connolly, et al.
Frontiers in Pharmacology
|
October 5, 2020
The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer
Matthias Piesche, Jessica Roos, Benjamin Kühn, et al.
Frontiers in Immunology
|
February 17, 2025
Analysis of fatty acid-derived lipids in critically ill patients after cardiac surgery yields novel pathophysiologically relevant mediators with possible relevance for systemic inflammatory reactions
Holger Neb, Verena Roth, Jessica Roos, et al.
Blood Advances
|
January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT
Vincent T Ho, Haesook T Kim, Natalie Bavli, et al.
Pharmacology & Therapeutics
|
November 10, 2015
Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells?
Jessica Roos, Sabine Grösch, Oliver Werz, et al.
Cancer Immunology Research
|
May 20, 2017
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
Jun Zhou, Kathleen M Mahoney, Anita Giobbie-Hurder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2014
Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions
Matthias Piesche, Vincent T Ho, Haesook Kim, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The Journal of Clinical Investigation
|
January 28, 2006
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
Marco Prinz, Folker Garbe, Hauke Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2016
Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma
William T Curry, Ramana Gorrepati, Matthias Piesche, et al.
Frontiers in Pharmacology
|
March 22, 2021
Effects of Interleukin-1β in Glycinergic Transmission at the Central Amygdala
Jocelyn Solorza, Carolina A Oliva, Karen Castillo, et al.
Cancer Immunology Research
|
May 6, 2017
Combined Anti-VEGF and Anti-CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes
Xinqi Wu, Jingjing Li, Erin M Connolly, et al.
Frontiers in Pharmacology
|
October 5, 2020
The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer
Matthias Piesche, Jessica Roos, Benjamin Kühn, et al.
Frontiers in Immunology
|
February 17, 2025
Analysis of fatty acid-derived lipids in critically ill patients after cardiac surgery yields novel pathophysiologically relevant mediators with possible relevance for systemic inflammatory reactions
Holger Neb, Verena Roth, Jessica Roos, et al.
Blood Advances
|
January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT
Vincent T Ho, Haesook T Kim, Natalie Bavli, et al.
Pharmacology & Therapeutics
|
November 10, 2015
Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells?
Jessica Roos, Sabine Grösch, Oliver Werz, et al.
Cancer Immunology Research
|
May 20, 2017
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
Jun Zhou, Kathleen M Mahoney, Anita Giobbie-Hurder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2014
Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions
Matthias Piesche, Vincent T Ho, Haesook Kim, et al.
Page
of 3